Post Categories
Precision Steering of CAR-T Therapies May Effectively Target More Tumor Types
March 13, 2023
Recent years have seen increased research interest in the potential of chimeric antigen receptor (CAR)-T cancer therapies. This approach uses genetic engineering to modify…
First Malaria Vaccine Is a Milestone Achievement and Poses a Manufacturing Challenge
March 6, 2023
Following 30 years of research and development, the first malaria vaccine was recommended by the World Health Organization (WHO) for widespread use in children…
Genome Sequencing Labs in Africa and Asia Expand Beyond COVID-19 to Endemic Diseases
February 27, 2023
Funding unlocked during the COVID-19 pandemic allowed many countries in Asia and Africa to perform in-house genome sequencing, resulting in faster results and action…
Flush Analysis Reveals Potentially Harmful Plumes from Powerful Public Toilets
February 20, 2023
Flushing a toilet sends waste and water down, but do you ever wonder about what is sprayed up into the air at the same…
Is Stool Screening an Effective Tool for Preventing Colon Cancer?
February 15, 2023
Colonoscopies have historically been the dominant method of screening for early detection of colon cancer, the third leading cause of cancer death in the…
Research on Extending Lifespan with Cell Reprogramming Yields “Cautious Optimism”
February 13, 2023
Investors are pouring hundreds of millions of dollars into research designed to minimize the harms of aging through genetic engineering. The San Diego-based biotech,…
Experimental mRNA Vaccine Takes a Multivalent Approach to the Flu
February 6, 2023
The events of the COVID-19 pandemic have largely upended how we perceive and respond to global viral threats. One positive change is the technology…
Discovery: Pupal Ants Produce Milk for Their Colonies
February 1, 2023
Pupating ants produce milk — and scientists have only just noticed. Research published in Nature in November describes researchers observing for the first time…
The Resurgence of Strep A and the Effects of the COVID-19 Pandemic
January 30, 2023
An unexpected increase in cases of streptococcal A (strep A) infection in the United Kingdom is troubling for families, healthcare practitioners, and researchers. Although…
Pigs Could Solve the Organ Transplant Crisis
January 25, 2023
2022 held a number of significant breakthroughs in researchers’ ongoing efforts to solve the organ transplant crisis. Many of those breakthroughs were in xenotransplantation,…
The Unlikely Role of Hops in the Prevention of Alzheimer’s Disease
January 23, 2023
A team of Italian scientists from the University of Milan-Bicocca have recently discovered a possible use of hops, the flowers used to enhance both…
Costly, Life-Changing Type 1 Diabetes Drug Delays Disease, Receives FDA Approval
January 16, 2023
The U.S. Food and Drug Administration has approved teplizumab-mzw (TZIELD™), a drug developed by New Jersey-based Provention Bio to delay the onset of type…
Exciting New Epilepsy Drug Reduces Seizures
October 30, 2024
Epilepsy affects as many as 50 million people worldwide, with a broad range of disease subtypes with limited treatment options. Fortunately, a new epilepsy…
Could Gene Therapy in Cows Slow Climate Change?
October 28, 2024
Despite the impact of companies like Impossible Foods, which markets plant-based imitation meat products, the demand for beef has never been higher. As of…
Weight Loss Drug Prescriptions Become More Accessible With Single-Dose Option
October 21, 2024
Eli Lilly has launched a new way for patients to access its popular weight loss drug, Zepbound® (tirzepatide). The company now offers single-dose vials…
Sizing Up Potential Medicare Costs of Covering Weight Loss Drugs for Heart Health
October 14, 2024
Medicare may soon face steeply increased prescription drug costs as it considers covering the popular weight loss drug, Wegovy® (semaglutide). Known for its ability…
Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso…
Advancing CRISPR-Based Treatment for Rare Swelling Disease
September 30, 2024
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the Phase II clinical trial of NTLA-2002, a CRISPR-based therapy targeting hereditary angioedema (HAE),…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
GRONINGEN, Netherlands–(BUSINESS WIRE)–QPS Holdings, LLC (QPS) today announced a significant renewal of its elemental bioanalysis infrastructure through the acquisition of two PerkinElmer NexION® 2200…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…